A Controlled Study of Uric Acid on the Progression of IgA Nephropathy

IgA Nephropathy

Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease Phase III Study of Telitacicept in Patients With IgA Nephropathy Oxford Classification and Clinical Remission After Initial Treatments in Patients With IgA Nephropathy TESTING -ON Post-Trial ObservatioNal Cohort Study A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject Bortezomib for Treating Glomerular Diseases Correlation of Microbiome and Metabonomics With IgA Nephropathy A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN) Study of ALXN2050 in Proliferative Lupus Nephritis (LN) and Immunoglobulin A Nephropathy (IgAN) A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy. A Phase 2 Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA) Steroids Therapy in IgA Nephropathy With Crescents SodiUm Restriction by Behavioral Intevention Atacicept in Subjects With IgA Nephropathy Open-Label Extension Study of BION-1301 in IgA Nephropathy Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients Atrasentan in Patients With Proteinuric Glomerular Diseases Atrasentan in Patients With IgA Nephropathy A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy Rituximab and RASi in Patients With IgAN The Role of T/B Cell Repertoire in Non-invasive Diagnosis and Disease Monitoring in Patients With IgA Nephropathy Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies First in Human Study to Assess Safety of VIS649 in Healthy Subjects KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy Safety and Efficacy Study of VIS649 for IgA Nephropathy Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy Aliskiren for Immunoglobulin A (IgA) Nephropathy Steroids and Azathioprine in Advanced IgAN Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy A Study of RC18 Administered Subcutaneously to Subjects With IgA(Immunoglobulin A) Nephropathy A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy Paricalcitol for the Treatment of Immunoglobulin A Nephropathy Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy “Steroids and Azathioprine Versus Steroids Alone in IgAN” Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f. A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers Pilot Study of Velcade® in IgA Nephropathy Diet Intervention in Food Sensitive Patients With IgA Nephropathy Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy Biomarkers for the Progression of IgA Nephropathy Oral Treatment With PL-56 in Patients With IgA Nephropathy – an Explorative Study Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy Probiotics in IgA Nephropathy A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients Mycophenolate Mofetil for IgA Nephropathy Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy Registry of IgA Nephropathy in Chinese Children IgA Nephropathy, Lymphocyte Homing and IgA Class Switch Treatment of IgA Nephropathy According to Renal Lesions Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN) An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN) Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy Efficacy and Safety of Atacicept in IgA Nephropathy Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy Rituximab in Recurrent IgA Nephropathy Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy IgA Nephropathy Biomarkers Evaluation Study (INTEREST) Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy Fecal Microbiota Transplantation for Refractory IgA Nephropathy An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) A Controlled Study of Uric Acid on the Progression of IgA Nephropathy A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy IgA Nephropathy Registration Initiative of High Quality (INSIGHT)